# MYRF

## Overview
The MYRF gene encodes the myelin regulatory factor, a membrane-bound transcription factor that plays a pivotal role in the development and maintenance of myelin in the central nervous system (CNS). The MYRF protein is characterized by its complex structure, which includes a DNA-binding domain, an intramolecular chaperone auto-processing domain, and a transmembrane domain. This protein undergoes autoproteolytic cleavage, releasing a fragment that translocates to the nucleus to regulate the expression of myelin-related genes. MYRF functions as a homotrimer in the nucleus, binding to specific DNA sequences to activate genes essential for oligodendrocyte differentiation and myelination. It interacts with other transcription factors, such as Sox10, to coordinate myelin gene expression. Mutations in the MYRF gene are associated with various human diseases, including nanophthalmos, congenital diaphragmatic hernia, and mild encephalopathy with reversible myelin vacuolization, highlighting its critical role in normal neurological function and development (Kurahashi2018MYRFis; Bujalka2013MYRF; Li2013A).

## Structure
The MYRF protein is a membrane-bound transcription factor with a complex molecular structure. It contains a DNA-binding domain (DBD), an intramolecular chaperone auto-processing (ICA) domain, and a transmembrane domain. The DBD of MYRF exhibits an immunoglobulin-like (Ig-like) fold, specifically an s-type Ig-fold, characterized by a β-sandwich formed by two antiparallel β-sheets (Zhen2017Crystal; Chen2018Structure). The DBD forms a trimeric assembly in the crystal, although it exists as a monomer in solution (Chen2018Structure).

The ICA domain is crucial for MYRF's autocatalytic self-cleavage and trimerization. It shares homology with the triple-β-helix and intramolecular chaperone autocleavage domain of phage tailspike proteins. The trimerization is driven by a triple α-helical coiled-coil structure, which is essential for the cleavage and release of MYRF from the endoplasmic reticulum to the nucleus (Wu2021Crystal). The ICA domain facilitates the correct folding and trimerization of the protein, although it does not interact significantly with the upstream β-helical stalk (Wu2021Crystal).

MYRF undergoes autoproteolytic cleavage, releasing the N-terminal fragment, which includes the DBD, to enter the nucleus and regulate gene expression (Li2013A). The protein may have multiple isoforms due to alternative splicing, which could affect its functional properties.

## Function
MYRF (myelin regulatory factor) is a membrane-bound transcription factor essential for the differentiation of oligodendrocytes and the development and maintenance of myelin in the central nervous system (CNS). MYRF is initially synthesized as a type-II membrane protein and undergoes autoproteolytic cleavage, a process facilitated by a domain similar to bacteriophage tailspike proteins. This cleavage releases the N-terminal transcription factor domain, which translocates to the nucleus to regulate gene expression (Bujalka2013MYRF; Li2013A).

In the nucleus, MYRF functions as a homotrimer, binding to specific DNA consensus sequences to activate the transcription of myelin-related genes. It directly targets genes involved in oligodendrocyte differentiation and myelination, such as those encoding myelin proteins like Mbp, Plp1, Mag, and Mog (Bujalka2013MYRF; Zhen2017Crystal). MYRF's activity is crucial for the maturation of oligodendrocytes and the formation of myelin sheaths, which are vital for efficient nerve signal transmission (Kurahashi2018MYRFis; Li2013A).

MYRF also interacts with other transcription factors, such as Sox10, to coordinate the expression of myelin genes, ensuring proper myelin development and maintenance (Huang2021MYRF:; Kurahashi2018MYRFis). Its function is critical for maintaining healthy myelin in human cells, contributing to normal neurological function and psychomotor development (Kurahashi2018MYRFis).

## Clinical Significance
Mutations in the MYRF gene are associated with several human diseases and conditions. MYRF mutations can lead to nanophthalmos, a condition characterized by small eyes, high hyperopia, and retinal degeneration. A specific variant, MYRF c.3376-1G>A, alters mRNA splicing, affecting the C-terminus of the protein and contributing to the pathogenesis of nanophthalmos (Garnai2019Variants). MYRF mutations are also linked to congenital diaphragmatic hernia (CDH), cardiac defects, and urogenital anomalies. These mutations often involve de novo variants that are highly penetrant and can lead to a range of developmental disorders (Qi2018De).

In the central nervous system, MYRF mutations can cause mild encephalopathy with reversible myelin vacuolization (MMERV), a rare genetic disorder characterized by reversible neuroimaging features and neurological symptoms such as seizures and impaired consciousness. This condition is associated with missense mutations in the DNA-binding domain of MYRF, which reduce the transcriptional activity of myelin genes (Yao2023MYRFrelated; Kurahashi2018MYRFis).

MYRF mutations may also be implicated in other conditions, such as late-onset Alzheimer's disease and blood pressure regulation, although these associations require further confirmation (Xiao2019Novel).

## Interactions
MYRF (myelin regulatory factor) is involved in several interactions with other proteins and nucleic acids that are crucial for its function in myelination. MYRF undergoes autoproteolytic cleavage, releasing its N-terminal fragment, which functions as a transcription factor. This fragment translocates to the nucleus, where it binds to and activates genes involved in myelination (Bujalka2013MYRF). The N-terminal fragment of MYRF forms stable homo-trimers, which are essential for its DNA binding specificity and transcriptional activity. This trimerization occurs before the fragments are released from the endoplasmic reticulum (Kim2017Homotrimerization).

MYRF interacts with the transcription factor Sox10, which induces MYRF expression. Once expressed, MYRF physically and functionally interacts with Sox10 to activate myelin genes. This interaction involves the carboxyterminal part of MYRF and the DNA-binding HMG domain of Sox10 (Hornig2013The). MYRF also binds to a specific DNA consensus sequence, CTGGYAC, which is crucial for its role in activating myelin genes (Bujalka2013MYRF).

MYRF is regulated by the ubiquitin ligase Fbxw7α, which targets its nuclear form for degradation, thus controlling its accumulation and activity in cells (Nakayama2018Degradation).


## References


[1. (Kurahashi2018MYRFis) Hirokazu Kurahashi, Yoshiteru Azuma, Akio Masuda, Tatsuya Okuno, Eri Nakahara, Takuji Imamura, Makiko Saitoh, Masashi Mizuguchi, Toshiaki Shimizu, Kinji Ohno, and Akihisa Okumura. Myrfis associated with encephalopathy with reversible myelin vacuolization. Annals of Neurology, 83(1):98–106, January 2018. URL: http://dx.doi.org/10.1002/ana.25125, doi:10.1002/ana.25125. This article has 36 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1002/ana.25125)

[2. (Hornig2013The) Julia Hornig, Franziska Fröb, Michael R. Vogl, Irm Hermans-Borgmeyer, Ernst R. Tamm, and Michael Wegner. The transcription factors sox10 and myrf define an essential regulatory network module in differentiating oligodendrocytes. PLoS Genetics, 9(10):e1003907, October 2013. URL: http://dx.doi.org/10.1371/journal.pgen.1003907, doi:10.1371/journal.pgen.1003907. This article has 170 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1371/journal.pgen.1003907)

[3. (Yao2023MYRFrelated) Shumei Yao, Xiufeng Mo, Changjiang Luo, and Chuanqiang Qu. Myrf-related mild encephalopathy with reversible myelin vacuolization: a case report and literature review. Frontiers in Genetics, December 2023. URL: http://dx.doi.org/10.3389/fgene.2023.1284060, doi:10.3389/fgene.2023.1284060. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fgene.2023.1284060)

[4. (Bujalka2013MYRF) Helena Bujalka, Matthias Koenning, Stacey Jackson, Victoria M. Perreau, Bernard Pope, Curtis M. Hay, Stanlislaw Mitew, Andrew F. Hill, Q. Richard Lu, Michael Wegner, Rajini Srinivasan, John Svaren, Melanie Willingham, Ben A. Barres, and Ben Emery. Myrf is a membrane-associated transcription factor that autoproteolytically cleaves to directly activate myelin genes. PLoS Biology, 11(8):e1001625, August 2013. URL: http://dx.doi.org/10.1371/journal.pbio.1001625, doi:10.1371/journal.pbio.1001625. This article has 204 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1371/journal.pbio.1001625)

[5. (Zhen2017Crystal) Xiangkai Zhen, Bowen Li, Fen Hu, Shufeng Yan, Gabriele Meloni, Huiliang Li, and Ning Shi. Crystal structure of the dna-binding domain of myelin-gene regulatory factor. Scientific Reports, June 2017. URL: http://dx.doi.org/10.1038/s41598-017-03768-9, doi:10.1038/s41598-017-03768-9. This article has 10 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-017-03768-9)

[6. (Chen2018Structure) Baohua Chen, Yun Zhu, Sheng Ye, and Rongguang Zhang. Structure of the dna-binding domain of human myelin-gene regulatory factor reveals its potential protein-dna recognition mode. Journal of Structural Biology, 203(2):170–178, August 2018. URL: http://dx.doi.org/10.1016/j.jsb.2018.04.007, doi:10.1016/j.jsb.2018.04.007. This article has 10 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.jsb.2018.04.007)

[7. (Wu2021Crystal) Pei Wu, Xiangkai Zhen, Bowen Li, Qian Yu, Xiaochen Huang, and Ning Shi. Crystal structure of the myrf ica domain with its upstream β-helical stalk reveals the molecular mechanisms underlying its trimerization and self-cleavage. International Journal of Biological Sciences, 17(11):2931–2943, 2021. URL: http://dx.doi.org/10.7150/ijbs.57673, doi:10.7150/ijbs.57673. This article has 5 citations and is from a peer-reviewed journal.](https://doi.org/10.7150/ijbs.57673)

[8. (Xiao2019Novel) Xueshan Xiao, Wenmin Sun, Jiamin Ouyang, Shiqiang Li, Xiaoyun Jia, Zhiqun Tan, J. Fielding Hejtmancik, and Qingjiong Zhang. Novel truncation mutations in myrf cause autosomal dominant high hyperopia mapped to 11p12–q13.3. Human Genetics, 138(10):1077–1090, June 2019. URL: http://dx.doi.org/10.1007/s00439-019-02039-z, doi:10.1007/s00439-019-02039-z. This article has 24 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s00439-019-02039-z)

[9. (Qi2018De) Hongjian Qi, Lan Yu, Xueya Zhou, Julia Wynn, Haoquan Zhao, Yicheng Guo, Na Zhu, Alexander Kitaygorodsky, Rebecca Hernan, Gudrun Aspelund, Foong-Yen Lim, Timothy Crombleholme, Robert Cusick, Kenneth Azarow, Melissa E. Danko, Dai Chung, Brad W. Warner, George B. Mychaliska, Douglas Potoka, Amy J. Wagner, Mahmoud ElFiky, Jay M. Wilson, Debbie Nickerson, Michael Bamshad, Frances A. High, Mauro Longoni, Patricia K. Donahoe, Wendy K. Chung, and Yufeng Shen. De novo variants in congenital diaphragmatic hernia identify myrf as a new syndrome and reveal genetic overlaps with other developmental disorders. PLOS Genetics, 14(12):e1007822, December 2018. URL: http://dx.doi.org/10.1371/journal.pgen.1007822, doi:10.1371/journal.pgen.1007822. This article has 78 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1371/journal.pgen.1007822)

[10. (Garnai2019Variants) Sarah J. Garnai, Michelle L. Brinkmeier, Ben Emery, Tomas S. Aleman, Louise C. Pyle, Biliana Veleva-Rotse, Robert A. Sisk, Frank W. Rozsa, Ayse Bilge Ozel, Jun Z. Li, Sayoko E. Moroi, Steven M. Archer, Cheng-mao Lin, Sarah Sheskey, Laurel Wiinikka-Buesser, James Eadie, Jill E. Urquhart, Graeme C.M. Black, Mohammad I. Othman, Michael Boehnke, Scot A. Sullivan, Gregory L. Skuta, Hemant S. Pawar, Alexander E. Katz, Laryssa A. Huryn, Robert B. Hufnagel, Sally A. Camper, Julia E. Richards, and Lev Prasov. Variants in myelin regulatory factor (myrf) cause autosomal dominant and syndromic nanophthalmos in humans and retinal degeneration in mice. PLOS Genetics, 15(5):e1008130, May 2019. URL: http://dx.doi.org/10.1371/journal.pgen.1008130, doi:10.1371/journal.pgen.1008130. This article has 54 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1371/journal.pgen.1008130)

[11. (Kim2017Homotrimerization) Dongkyeong Kim, Jin-ok Choi, Chuandong Fan, Randall S. Shearer, Mohamed Sharif, Patrick Busch, and Yungki Park. Homo-trimerization is essential for the transcription factor function of myrf for oligodendrocyte differentiation. Nucleic Acids Research, 45(9):5112–5125, February 2017. URL: http://dx.doi.org/10.1093/nar/gkx080, doi:10.1093/nar/gkx080. This article has 41 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1093/nar/gkx080)

[12. (Huang2021MYRF:) Hao Huang, Fang Zhou, Shiyou Zhou, and Mengsheng Qiu. Myrf: a mysterious membrane-bound transcription factor involved in myelin development and human diseases. Neuroscience Bulletin, 37(6):881–884, April 2021. URL: http://dx.doi.org/10.1007/s12264-021-00678-9, doi:10.1007/s12264-021-00678-9. This article has 12 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s12264-021-00678-9)

[13. (Nakayama2018Degradation) Shogo Nakayama, Kanae Yumimoto, Atsuki Kawamura, and Keiichi I. Nakayama. Degradation of the endoplasmic reticulum–anchored transcription factor myrf by the ubiquitin ligase scffbxw7 in a manner dependent on the kinase gsk-3. Journal of Biological Chemistry, 293(15):5705–5714, April 2018. URL: http://dx.doi.org/10.1074/jbc.ra117.000741, doi:10.1074/jbc.ra117.000741. This article has 13 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.ra117.000741)

[14. (Li2013A) Zhihua Li, Yungki Park, and Edward M. Marcotte. A bacteriophage tailspike domain promotes self-cleavage of a human membrane-bound transcription factor, the myelin regulatory factor myrf. PLoS Biology, 11(8):e1001624, August 2013. URL: http://dx.doi.org/10.1371/journal.pbio.1001624, doi:10.1371/journal.pbio.1001624. This article has 62 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1371/journal.pbio.1001624)